176 related articles for article (PubMed ID: 3904801)
1. Immunohistochemical detection of the ras oncogene p21 product in an experimental tumour and in human colorectal neoplasms.
Williams AR; Piris J; Spandidos DA; Wyllie AH
Br J Cancer; 1985 Nov; 52(5):687-93. PubMed ID: 3904801
[TBL] [Abstract][Full Text] [Related]
2. Immunocytochemical demonstration of p21 ras family oncogene product in normal mucosa and in premalignant and malignant tumours of the colorectum.
Kerr IB; Lee FD; Quintanilla M; Balmain A
Br J Cancer; 1985 Nov; 52(5):695-700. PubMed ID: 3904802
[TBL] [Abstract][Full Text] [Related]
3. ras p21 oncoprotein expression in human colonic neoplasia--an immunohistochemical study with monoclonal antibody RAP-5.
Lanza G
Histopathology; 1988 Jun; 12(6):595-609. PubMed ID: 3047043
[TBL] [Abstract][Full Text] [Related]
4. An immunohistochemical analysis of ras oncogene expression in epithelial neoplasms of the colon.
Jansson DS; Radosevich JA; Carney WP; Rosen ST; Schlom J; Staren ED; Hyser MJ; Gould VE
Cancer; 1990 Mar; 65(6):1329-37. PubMed ID: 2407334
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical staining of colorectal tissues with monoclonal antibodies to ras oncogene p21 product and carbohydrate determinant antigen 19-9.
Allen DC; Foster H; Orchin JC; Biggart JD
J Clin Pathol; 1987 Feb; 40(2):157-62. PubMed ID: 3546394
[TBL] [Abstract][Full Text] [Related]
6. Enhanced expression of c-Ha-ras p21 in human stomach adenocarcinomas defined by immunoassays using monoclonal antibodies and in situ hybridization.
Ohuchi N; Hand PH; Merlo G; Fujita J; Mariani-Costantini R; Thor A; Nose M; Callahan R; Schlom J
Cancer Res; 1987 Mar; 47(5):1413-20. PubMed ID: 2434216
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical analysis of the ras oncogene protein product in human thyroid neoplasms.
Papadimitriou K; Yiagnisis M; Tolis G; Spandidos DA
Anticancer Res; 1988; 8(6):1223-7. PubMed ID: 3064713
[TBL] [Abstract][Full Text] [Related]
8. Ras oncogene and the acquisition of metastasizing properties by rectal adenocarcinoma.
Michelassi F; Erroi F; Roncella M; Block GE
Dis Colon Rectum; 1989 Aug; 32(8):665-8. PubMed ID: 2666052
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a monoclonal antibody to ras peptide, RAP-5, claimed to bind preferentially to cells of infiltrating carcinomas.
Robinson A; Williams AR; Piris J; Spandidos DA; Wyllie AH
Br J Cancer; 1986 Dec; 54(6):877-83. PubMed ID: 3542007
[TBL] [Abstract][Full Text] [Related]
10. Expression of ras oncogene p21 protein in early gastric carcinoma and adjacent gastric epithelia.
Czerniak B; Herz F; Gorczyca W; Koss LG
Cancer; 1989 Oct; 64(7):1467-73. PubMed ID: 2550123
[TBL] [Abstract][Full Text] [Related]
11. Ras oncogene p21 levels parallel malignant potential of different human colonic benign conditions.
Michelassi F; Leuthner S; Lubienski M; Bostwick D; Rodgers J; Handcock M; Block GE
Arch Surg; 1987 Dec; 122(12):1414-6. PubMed ID: 3318757
[TBL] [Abstract][Full Text] [Related]
12. Comparative immunohistochemical reactivity of monoclonal and polyclonal antibodies to H-ras p21 in normal and neoplastic tissues of rodents and humans.
Ward JM; Perantoni AO; Santos E
Oncogene; 1989 Feb; 4(2):203-13. PubMed ID: 2648257
[TBL] [Abstract][Full Text] [Related]
13. Phosphotyrosine, p62 c-myc and p21 c-Ha-ras proteins in colonic epithelium of normal and dimethylhydrazine-treated rats: an immunohistochemical analysis.
Schwartz B; Benharroch D; Prinsloo I; Cagnano E; Lamprecht SA
Anticancer Res; 1995; 15(1):211-8. PubMed ID: 7537485
[TBL] [Abstract][Full Text] [Related]
14. [Immunohistochemical study of oncogene-related products in human gastrointestinal malignancies--expression of ras p 21, fes p 85 and EGF receptor].
Kitagami S; Itabashi M; Hirota T; Hayashi I; Hojo K; Moriya Y; Maruyama K; Okabayashi K
Gan No Rinsho; 1986 Dec; 32(15):1950-8. PubMed ID: 2433473
[TBL] [Abstract][Full Text] [Related]
15. Expression of EGF, EGF-receptor, p53, v-erb B and ras p21 in colorectal neoplasms by immunostaining paraffin-embedded tissues.
Hayashi Y; Widjono YW; Ohta K; Hanioka K; Obayashi C; Itoh K; Imai Y; Itoh H
Pathol Int; 1994 Feb; 44(2):124-30. PubMed ID: 7912978
[TBL] [Abstract][Full Text] [Related]
16. DNA flow cytometry of endoscopically examined colorectal adenomas and adenocarcinomas.
Giaretti W; Sciallero S; Bruno S; Geido E; Aste H; Di Vinci A
Cytometry; 1988 May; 9(3):238-44. PubMed ID: 3378458
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical detection of RAS, JUN, FOS, and p53 oncoprotein expression in human colorectal adenomas and carcinomas.
Magrisso IJ; Richmond RE; Carter JH; Pross CB; Gilfillen RA; Carter HW
Lab Invest; 1993 Dec; 69(6):674-81. PubMed ID: 8264230
[TBL] [Abstract][Full Text] [Related]
18. DNA content and the adenoma-carcinoma sequence in the colorectum.
Goh HS; Jass JR
J Clin Pathol; 1986 Apr; 39(4):387-92. PubMed ID: 3700672
[TBL] [Abstract][Full Text] [Related]
19. ras oncogene p21 as a tumor marker in the cytodiagnosis of gastric and colonic carcinomas.
Czerniak B; Herz F; Koss LG; Schlom J
Cancer; 1987 Nov; 60(10):2432-6. PubMed ID: 3311346
[TBL] [Abstract][Full Text] [Related]
20. Optimal preservation of p21 ras immunoreactivity and morphology in paraffin-embedded tissue.
Going JJ; Williams AR; Wyllie AH; Anderson TJ; Piris J
J Pathol; 1988 Jul; 155(3):185-90. PubMed ID: 3045276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
